Compare Krispy Kreme Inc (DNUT) vs Exelixis Inc. Common Stock (EXEL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Krispy Kreme Inc vs Exelixis Inc. Common Stock — how do they compare? Krispy Kreme Inc trades at $3.01 (market cap $508.36M), while Exelixis Inc. Common Stock trades at $59.43 (market cap $14.48B). The key difference: Exelixis Inc. Common Stock is far larger — about 28.5× Krispy Kreme Inc's market cap, and Krispy Kreme Inc pays a 3.47% dividend while Exelixis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Krispy Kreme Inc for 45 Days and Exelixis Inc. Common Stock for 0 Days on average.
| DNUT | EXEL | |
|---|---|---|
Market Cap | $508.36M | $14.48B |
Volume | 1,955,706 | 2,374,774 |
Sector | Consumer Staples | Health |
52-Week High | $4.70 | $59.13 |
52-Week Low | $2.87 | $34.54 |
Typical Hold Time | 45 Days | 0 Days |
Enterprise Value | $1.75B | $13.81B |
Dividend Yield | 3.47% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Krispy Kreme (DNUT) trades at $3.01, down 0.33% on the day, with a bearish technical signal. The company reported a net loss of $515.77 million in 2025, despite a 75.19% gross margin, and faces legal investigations into fiduciary duties. Revenue declined to $1.52 billion in 2025 from $1.7 billion in 2024.
The outlook is cautious due to persistent losses and legal overhangs, though analyst consensus leans buy. Key risks include profitability challenges and high debt. Upside depends on operational turnaround and new product launches driving growth.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Krispy Kreme Inc
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →About Exelixis Inc. Common Stock
Exelixis develops and commercializes medicines for cancer. Its research focuses on targeted therapies for oncology.
Read more on EXEL →
